Walgreens Clinical Trials
By Curebase
Walgreens Clinical Trials is a B2B-linked mobile platform for patients to manage remote clinical study participation on iOS and Android.
The App DNA
What makes this app unique?
The app removes the administrative friction of site visits by digitizing document signing, record uploads, and telehealth for enrolled study participants.
For Patients currently enrolled in specific clinical trials managed by Curebase and its partners.
What does it look like?
Key features
Centralized dashboard for document signing and questionnaires. Revenue link: B2B partnership core utility for sponsor compliance.
In-app interface for provider meetings. Revenue link: B2B partnership reducing site-visit overhead.
Secure portal for data submission. Revenue link: B2B partnership automating researcher data ingestion.
Interface for reimbursement. Revenue link: Retention mechanism increasing trial completion rates.
How much does it cost?
The application is a B2B tool provided to enrolled clinical trial participants at no cost, with revenue generated through enterprise contracts with clinical trial sponsors.
Velocity
Maintenance developmentopaqueperformanceShow more...
Development momentum is currently in a maintenance state, with only two distinct versions identified in the recent window. The latest release occurred 52 days ago, while the iOS platform has not seen an update in 736 days. The release notes for the most recent update are opaque, providing no insight into specific feature changes or improvements. Given the lack of consistent activity and the absence of clear feature development, the app appears to be in a long-term maintenance cycle.
Who built it?
User Sentiment
What do users think recently?
Recent user voice shows an excited sentiment. Users appreciate clinical trial participation feels accessible and straightforward for users seeking to contribute to research and automated survey reminders help participants maintain engagement with the clinical trial requirements over time.
How are ratings & reviews evolving?
What users say, by theme
- Clinical trial participation feels accessible and straightforward for users seeking to contribute to research
- Automated survey reminders help participants maintain engagement with the clinical trial requirements over time
- Users report difficulty locating available clinical trials within the interface, leading to concerns about app functionality
9 of 9 recent reviews analyzed · limited sample · Excited overall
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Walgreens Clinical Trials
How's the Medical market?
Walgreens Clinical Trials functions as a specialized B2B utility for decentralized research, with a 1.0-star rating on iOS and a 3.8-star rating on Android across a small sample of 23 total ratings. The disparity in platform stability suggests a lack of parity in the current maintenance-mode release cycle.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Walgreens Clinical Trials
Where is it heading?
The decentralized clinical trial market is consolidating around platforms that offer high-fidelity participant engagement, leaving Walgreens Clinical Trials exposed due to its stagnant release cadence. The current inability for users to find active trials will likely lead to increased sponsor churn if the discovery funnel is not prioritized in the next release cycle.
- The lack of updates for over 52 days signals a maintenance-only posture, which erodes participant trust in the app's reliability.
- User reports of being unable to locate active trials suggest a broken discovery funnel, which directly impacts trial completion rates.
The SWOT
- Automated survey reminders maintain participant engagement across long-term study cycles.
- Improved search visibility for active trials would resolve the #1 user frustration theme.
Next best moves
Audit search visibility because users report being unable to find active studies → reduce churn.
+ 1 more prioritized moveThe counter-intuitive read
The app's maintenance-mode status is a strategic risk for sponsors…
Read the full takeBottom line
Walgreens Clinical Trials requires a stability audit to address the 1.0-star iOS rating, as the current maintenance-mode cadence fails to support the basic discovery of active studies. Addressing these discovery failures would unlock participant trust and reduce the churn risk for trial sponsors.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] Play Store
Report last updated